Q1 2026 Holdings
Filed 2026-05-15 | 51 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $181.2M | 12,229,500 | 9.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $119.8M | 1,050,000 | 6.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $114.2M | 1,236,027 | 5.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $113.6M | 3,785,991 | 5.8% |
| State STR Spdr S&P 500 ETF T(SPY) | TR UNIT | 78462F103 | $109.3M | 168,000 | 5.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $108.8M | 2,259,889 | 5.5% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $103.4M | 3,399,900 | 5.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $102.2M | 1,500,000 | 5.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $95.4M | 1,892,200 | 4.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $92.1M | 4,573,530 | 4.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $88.8M | 16,790,809 | 4.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $83.4M | 1,188,624 | 4.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $79.9M | 2,649,368 | 4.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $73.8M | 1,330,879 | 3.7% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $60.5M | 1,500,000 | 3.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $54.4M | 707,500 | 2.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $42.5M | 260,000 | 2.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $41.8M | 470,000 | 2.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $35.1M | 1,792,626 | 1.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $25.9M | 4,814,700 | 1.3% |
| Precigen Inc(PGEN) | COM | 74017N105 | $24.8M | 6,417,500 | 1.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $22.2M | 264,692 | 1.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $22.1M | 4,002,200 | 1.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $21.3M | 1,160,000 | 1.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $16.3M | 500,000 | 0.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $16.3M | 500,000 | 0.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $15.0M | 450,000 | 0.8% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $13.5M | 3,149,557 | 0.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $7.7M | 6,143,132 | 0.4% |
| Journey MED Corp(DERM) | COM | 48115J109 | $7.6M | 1,610,000 | 0.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $7.0M | 500,000 | 0.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $6.4M | 35,000 | 0.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $6.3M | 350,000 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $5.7M | 538,658 | 0.3% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $5.3M | 4,245,085 | 0.3% |
| Moderna Inc(MRNA) | COM | 60770K107 | $5.1M | 100,000 | 0.3% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $5.0M | 6,250,000 | 0.3% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $4.9M | 664,314 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $4.4M | 600,000 | 0.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.1M | 451,114 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.4M | 100,000 | 0.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.2M | 200,000 | 0.2% |
| Coherus Oncology Inc(CHRS) | COM | 19249H103 | $3.2M | 1,886,748 | 0.2% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $3.1M | 1,480,823 | 0.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.1M | 666,022 | 0.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $2.0M | 483,021 | 0.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $1.8M | 400,000 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.4M | 1,167,773 | 0.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $857.8K | 439,878 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $623.5K | 399,700 | 0.0% |